Ingredient innovation under pressure: how food & beverage companies are responding

The food system is being rewritten in real time. Drought in Spain in 2022-2023 and record heat in West Africa more recently have sent olive-oil and cocoa prices soaring amongst other high-value ingredients. Changing consumer demand and regulation is pushing manufacturers to de-risk supply chains and cut scope-3 emissions. At the same time, new biological and fermentation platforms are moving from lab to commercial scale, offering ingredient parity (or near-parity) with lower land, water and carbon footprints. This article examines three converging trends, the technical and commercial trade-offs, and real examples of innovators to watch.

 

Ingredients in peril: from vulnerability to reinvention

Crops such as cocoa and coffee are geographically constrained and vulnerable to rising temperatures, extreme weather and disease; vanilla’s labour-intensive production is sensitive to both climate and market shocks, while olive oil yields and quality are affected by drought and heat. Where global supply shrinks, price volatility and reputational risk (deforestation, labour issues) increase for downstream brands. Corporates therefore face both operational and strategic exposure. Pragmatic levers are appearing like on-farm resilience (breeding, vertical farming…) which we discussed in our recent article Future-Proof Farming: Bold Moves (Part 2), ingredient substitution and cell/fermentation-derived molecules. Each lever trades authenticity, cost and social impact differently.

• Atomo Coffee (beanless coffee). Seattle-based Atomo recreates coffee’s flavour and functional profile using upcycled plant inputs like date seeds left over from making date paste for nutritional bars; retail and foodservice pilots (including partnerships with coffee chains in the US, Japan and the UK) highlight an early path to reducing land and water intensity in the coffee category. Investors in the brand now include the Japanese drinks giant Suntory.
• Win-Win (cocoa-free chocolate). Win-Win markets a cocoa-free chocolate made from fermented cereals and other plant inputs to mimic the sensory profile of chocolate while removing dependence on cocoa beans; this reduces exposure to cocoa price and ethical risks. This UK company claims 80% less water usage, 84% less GHG emissions and 100% less deforestation.
• Barry Callebaut. The world’s largest chocolate ingredient supplier is investing in cocoa cell-culture research and non-cocoa flavour solutions with the Zurich University of Applied Science (ZHAW) to diversify supply and reduce long-term climate exposure, while continuing to fund farmer adaptation programmes — a hybrid strategy blending tech and on-farm resilience.

Taste parity at scale, unit economics, regulatory clarity and preserving farmer livelihoods are the dominant risks. For brands, the commercial question is whether substitution or supplementation (blends, hybrid products) best preserves margin and trust.

 

Precision fermentation: programming microbes for flavour and function

Precision fermentation uses engineered microbes to make specific molecules (dairy proteins, egg proteins, enzymes, flavour precursors) identical to animal-derived counterparts. The microbes (whether yeast, fungus strains, or bacteria) are genetically-modified using CRISPR and are fed substrates to produce specific compounds that are then separated from the microbial biomass. For formulators this is powerful: identical functionality (foaming, emulsification, melt, mouthfeel) with potentially lower lifecycle impacts and fewer land/water constraints than livestock.

• Perfect Day. Using safe, proven fermentation methods, Perfect Day makes animal-free whey and casein protein from microflora instead of cows. Their proteins are used in a wide range of applications from cream cheese and barista milk to ice cream and bakery mixes. Current partners include Mars, Nestlé, and Myprotein.
• The EVERY Company, a B2B ingredient company from California, produces animal-identical egg proteins via fermentation for bakery, confectionery and industrial uses; Their OvoPro™ can be used to partially or fully replace the functionality of eggs or egg whites without the chicken – or the added chalkiness that usually comes with protein powder. Its ingredient launches and culinary trials (including with high-end chefs) show early commercial traction.
• DSM-firmenich combines AI-powered machine-learning with deep customer collaboration to rapidly test and identify optimal microbial culture blends for fermented-dairy applications – enabling them to evaluate “hundreds of billions” of possible combinations in silico, dramatically reducing trial time and waste. Their Delvo®ONE family of cultures integrates a starter culture, built-in bioprotective culture, and optional probiotic in a single “one-bag” solution, addressing texture, taste, shelf-life, bioprotection and cost-in-use simultaneously, rather than as isolated targets. By extending shelf-life, improving manufacturing efficiency, and offering formats suited to emerging markets (including freeze-dried and frozen options), they aim to reduce food waste and improve global access.

Precision fermentation’s principal bottlenecks are capital-intensive scale-up (bioreactors, downstream processing), regulatory harmonisation for novel ingredients and competitive cost curves versus commodity animal proteins. The current commercial playbook combines ingredient R&D, contract manufacturing and strategic partnerships with established ingredient multinationals.

 

Alternative proteins: the rise of fungi and cultivated meat

The alternative-protein landscape is diverse: fungal/mycelial whole-foods and extracts scale quickly and deliver texture; precision-fermented single-cell proteins offer ingredient versatility; cultivated meat produces animal tissue in reactors but requires breakthroughs in media costs and bioreactor economics. Choice of route depends on the product target (whole-cut, ground, functional ingredient) and regulatory pathway.

• Meati uses the mycelium of Neurospora crassa to produce high-quality protein through an efficient fermentation process similar to brewing. The fungus grows rapidly in nutrient-rich tanks, naturally generating a complete nutritional profile with high protein content. Its fibrous structure mimics the texture of meat, enabling the creation of realistic whole-cut alternatives (like cutlet or steak) while using far fewer resources than conventional animal farming. Recent financial strain in 2025 however underscores execution and capital risks in scaling novel whole-food businesses.
• Solar Foods, a Finnish start-up, uses biomass fermentation (not precision fermentation) to produce its protein powder Solein®. In biomass fermentation, the entire microorganism biomass is harvested as the final product, whereas precision fermentation uses microbes to produce specific proteins that are then separated from the rest of the culture. Solar Foods’ process involves growing microbes on air (CO2, water, nitrogen) and electricity, and the dried microbial mass becomes the protein powder. The Japanese food manufacturer the Ajinomoto Group has already launched several new products made with Solein® to consumers in Singapore under its brand, Atlr.72®.
• Ivy Farm Technologies, an Oxford University spin-out we featured as one of our tech spotlights a couple of years ago (here), is advancing the frontier of cultivated meat production. By harvesting a small number of animal cells and nurturing them in a bioreactor with a precisely formulated mix of vitamins and nutrients, the cells replicate into meat within just two to three weeks. Because the process bypasses conventional farmed animals, there is no need for antibiotics, significantly reducing the risk of contributing to antibiotic-resistant bacteria in humans.

For fungal/mycelial companies, the business case depends on reliable feedstock, fermentation economics and consumer acceptance. For cultivated meat, media costs, regulatory approvals and capex remain the key constraints; incumbents’ capital and distribution help, but cost parity is still distant.

 

Conclusion

Ingredient innovation is no longer a side project; it’s risk management. As climate pressure and regulatory scrutiny intensify, the most resilient food and beverage companies will be those blending new technologies with smarter sourcing and transparent partnerships.

Whether it’s protecting supply chains from climate and price risks, unlocking new functionality through precision fermentation, or exploring alternative proteins to meet future demand, the opportunity now lies in experimentation and collaboration.

At Strategic Allies Ltd, we help organisations connect with innovators and partners across this fast-moving ecosystem — identifying where biology, chemistry and supply chains can converge to drive growth and resilience.

If your business is exploring new ingredient strategies or would like to discuss emerging opportunities in these areas, contact John Allies (John@strategicallies.co.uk) or Sophie Graves (sophie@strategicallies.co.uk) for a confidential conversation.